Avid Bioservices and Argonaut Manufacturing Services Enter Agreement to Offer Biotechnology and Pharmaceutical Clients Integr...
28 July 2020 - 10:05PM
Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated
biologics contract development and manufacturing organization
(CDMO) working to improve patient lives by providing high quality
development and manufacturing services to biotechnology and
pharmaceutical companies, and Argonaut Manufacturing Services, a
CGMP contract manufacturing organization (CMO) dedicated to
providing custom manufacturing and supply chain solutions for life
science, molecular diagnostics, and biopharmaceutical companies,
today announced a co-marketing agreement that will provide clients
an integrated manufacturing solution including process development,
drug substance manufacturing, and drug product manufacturing.
Under terms of the non-exclusive agreement, the companies will
offer Avid’s upstream and downstream process development and drug
substance manufacturing services in tandem with Argonaut’s
parenteral drug product fill-finish services, to support the
efficient delivery of CGMP parenteral drug products for use in
clinical studies.
“As we continue to expand our biologics
manufacturing client base, Avid is leveraging a strategy of
aligning with industry leaders that are capable of offering
critical complementary services to our customers,”
said Timothy Compton, chief commercial officer of Avid. “In
entering this agreement with Argonaut, we are offering our clients
access to CGMP qualified parenteral fill-finish services within an
hour’s drive from our drug substance development and manufacturing
facilities. This will provide a drug substance-to-drug product
solution for our clients as they move their novel, high-value
biologic therapeutics through clinical development. Avid will be
well positioned to support Argonaut customers that require
downstream and upstream process development, as well as clinical
and commercial CGMP drug substance manufacturing services, by
delivering on our deep CDMO expertise and more than 15 years of
commercial manufacturing experience.”
“Argonaut has always endeavored to provide our
clients with a trusted network of complementary service providers
through our Ecosystem Partnership program,” said Eric Blair, chief
commercial officer of Argonaut. “Our partnership with Avid unlocks
key process development and drug substance manufacturing
capabilities for our clients, which are a perfect fit with our
state-of-the-art aseptic fill-finish offering. Together, Avid and
Argonaut offer a complete solution for customers that are bringing
biologic therapeutics to market.”
About Avid
Bioservices, Inc.
Avid Bioservices is a dedicated contract
development and manufacturing organization (CDMO) focused on
development and CGMP manufacturing of biopharmaceutical drug
substances derived from mammalian cell culture. The company
provides a comprehensive range of process development, CGMP
clinical and commercial manufacturing services for the
biotechnology and biopharmaceutical industries. With 27 years of
experience producing monoclonal antibodies and recombinant
proteins, Avid's services include CGMP clinical and commercial drug
substance manufacturing, bulk packaging, release and stability
testing and regulatory submissions support. For early-stage
programs, the company provides a variety of process development
activities, including upstream and downstream development and
optimization, analytical methods development, testing and
characterization. The scope of our services ranges from
standalone process development projects to full development and
manufacturing programs through commercialization.
www.avidbio.com
About Argonaut Manufacturing
Services
Argonaut Manufacturing Services is an FDA
registered, ISO 13485:2016 cGMP contract manufacturing organization
dedicated to providing custom manufacturing and supply chain
solutions for life science, molecular diagnostics, and
biopharmaceutical companies. Life sciences and molecular
diagnostics services include formulation, filling, lyophilization,
and kitting, while biopharmaceutical services feature
state-of-the-art automated aseptic fill-finish equipment for
sterile injectable drugs. All projects are supported by a full
analytical quality control service offering and global shipping
logistics. From procurement through pick-pack-ship, Argonaut
provides a wide range of flexible solutions for diverse outsourcing
needs. www.argonautms.com
Contacts:
Stephanie Diaz (Investors)
Vida Strategic Partners
415-675-7401
sdiaz@vidasp.com
Tim Brons (Media)
Vida Strategic Partners
415-675-7402
tbrons@vidasp.com
Eric Blair
Argonaut Manufacturing Services
760-224-0844
eric@argonautms.com
Avid Bioservices (NASDAQ:CDMO)
Historical Stock Chart
From Apr 2024 to May 2024
Avid Bioservices (NASDAQ:CDMO)
Historical Stock Chart
From May 2023 to May 2024